Oncology in neuroimmunomodulation: What progress has been made?

Annals of the New York Academy of Sciences

Volumn 917, Issue , 2000, Pages 68-83

  Conti, Ario ^a  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CYTOKINE; LEUCINE ENKEPHALIN; MELATONIN; METENKEPHALIN; OPIATE; PROOPIOMELANOCORTIN;

CANCER PATIENT; CONFERENCE PAPER; HISTORY; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOMODULATION; IMMUNOTHERAPY; MEDICAL RESEARCH; MUSIC THERAPY; NEUROIMMUNOLOGY; ONCOLOGY; RELAXATION TRAINING; STIMULUS RESPONSE;

EID: 0033676240     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05372.x     Document Type: Conference Paper

References (111)

1. Neuroimmune Interactions: Proceedings of the Second International Workshop on Neuroimmunomodulation
2. Epilogue
3. Ontogenetic and Phylogenetic Mechanisms of Neuroimmunomodulation: From Molecular Biology to Psychosocial Sciences
4. Neuroimmunomodulation: Molecular Aspects, Integrative Systems, and Clinical Advances
5. Neuroimmunoregulation and cancer
6. Opioid antagonists inhibit the growth of metastatic murine neuroblastoma
7. Endorphins, immune function and cancer
8. Opiate antagonists inhibit mammary tumor growth in rats
9. Suggestive evidence for morphine and methionine-enkephaline-like receptors on normal blood T lymphocytes
10. Neuroimmunomodulation with enkephalins: In vitro enhancement of natural killer cell activity in peripheral blood lymphocytes from cancer patients
11. Neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinoma
12. On the potential role of proopiomelanocortin in skin physiology and pathology
13. Interleukins and neurohormones: A common language
14. Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor
15. The clinical neuroimmunotherapeutic role of melatonin in oncology
16. Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: Its efficacy in preventing hypotension
17. Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancer
18. The biological significance of soluble interleukin-2 receptors in solid tumors
19. Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatonin
20. Endocrine effects of human recombinant interleukin-3 in cancer patients
21. Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients
22. A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients
23. Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: Preliminary results
24. Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2
25. A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms
26. Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancer
27. A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumor
28. Effects of low-dose recombinant interleukin-2 in human malignancies
29. Anticancer neuroimmunomodulation by pineal hormones other than melatonin: Preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatonin
30. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state
31. Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin
32. Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: Efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone
33. Interleukin-6: A comprehensive review
34. Regulation and role of intrapituitary IL-6 production by folliculostellate cells
35. Interleukin-7 and lymphopoiesis: Biological and clinical implications
36. Vasoactive intestinal polypeptide and related peptides: Isolation and chemistry
37. Selectivity of effects of vasoactive intestinal petide on macrophages and lymphocytes in compartmental immune responses
38. Modulatory effects of VIP and related peptides from the gastrointestinal tract on cell mediated cytotoxicity against tumor cells in vitro
39. Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS
40. The cytokine-like action of substance P upon B-cell differentiation
41. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: Potential autoregulatory role for these cytokines in SP receptor expression and induction
42. Prolactin: A hormone at the crossroads of neuroimmunoendocrinology
43. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus
44. Prolactin and the immune system
45. Coordinate gene expression of luteinizing hormone-releasing hormone (LHRH) and the LHRH receptor after prolactin stimulation in the rat Nb2 T-cell line: Implications for a role in neuroimmunomodulation and cell cycle gene expression
46. Growth hormone, prolactin and insulin-like growth factors: New jobs for old players
47. Insulin growth factor-I inhibits apoptosis in haematopoietic progenitor cells
48. Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin
49. Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice
50. Early socialization and development of cancer in later life: Biopsychosocial and psychoneuroimmunologic aspects
51. Stress, cancer and immunity. New developments in biopsychosocial and psychoneuroimmunologic research
52. Psychoneuroimmunology and cancer: Historical perspectives and current research
53. Interaction between breast cancer, psychosocial stress and the immune response
54. Psychoneuroimmunology and immunotoxicology: Implications for carcinogenesis
55. Children who have a parent with cancer: A pilot study
56. Psychosocial factors and breast cancer: A 6-year Italian follow-up study
57. Can loss and grief activate latent neoplasia? A clinical case of possible interaction between genetic risk and stress in breast cancer
58. Review of the effects of stress on cancer in laboratory animals: Importance of time of stress application and type of tumor
59. The effect of neonatal tactile stimulation on adult response to Ehrlich carcinoma in mice
60. Immunological consequences of maternal separation in infant primates
61. Effects of stress on tumor growth and metastasis in mice bearing Lewis lung carcinoma
62. Effects of rotational stress on the effectiveness of cyclophosphamide and razoxane in mice bearing Lewis lung carcinoma
63. A noninvasive simple method for measurement of urinary excretion of melatonin in undisturbed mice
64. Stress influence on development of hepatocellular tumors in transgenic mice overexpressing TGF alpha
65. Metastasis and neuroendocrine system in stressed mice
66. Seasonal effects of rotational stress on Lewis lung carcinoma metastasis and T lymphocyte subsets in mice
67. Role of pineal melatonin and melatonin-induced immuno-opioids in murine leukemogenesis
68. Survival time in mice bearing TLX5 lymphoma subjected to rotational stress and chemotherapy with CCNU
69. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity
70. Restraint stress reduces the antitumor efficacy of cyclophosphamide in tumor-bearing mice
71. Seasonal dependency of the effects of experimental stressors on tumor metastasis in mice bearing Lewis lung carcinoma
72. Blockers of adrenergic neurons and receptors, tumor progression and effects of rotational stress in mice
73. Is haematopoiesis under the influence of neural and neuroendocrine mechanisms?
74. Melatonin and the immunehaematopietic system. Therapeutic and adverse pharmacological correlates
75. Evidence for melatonin synthesis in mouse and human bone marrow cells
76. Identification of extremely high levels of melatonin in bone marrow: Its origin and significance
77. Neuroimmunomodulation in cancer patients: Correlations between melatonin and β-endorphin blood levels and T helper/suppressor ratio
78. Colony-stimulating activity and haematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin-4
79. Haematopoietic rescue via T-cell-dependent, endogenous GM-CSF by the pineal neurohormone melatonin in tumor bearing mice
80. Protective effect of melatonin in mice infected with encephalitis viruses
81. Melatonin secretion in oncologic patients: Current results and methodological considerations
82. Melatonin in oncology
83. Melatonin in human breast cancer tissue: Association with nuclear grade and estrogen receptor status
84. Knowledge and beliefs about breast cancer and breast self-examination among athletic and nonathletic women
85. Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to nonathletes
86. Lower prevalence of benign diseases of the breast and benign tumours of the reproductive system among former college athletes compared to nonathletes
87. Selected physical activities and the risk of endometrial cancer
88. Exercise, occupational activity, and risk of endometrial cancer
89. Past and present physical activity and endometrial cancer risk
90. Is exercise beneficial in the prevention of prostate cancer?
91. Sport activity and personality as elements in preventing cancer and coronary heart disease
92. Physical activity and cancer
93. Physical activity, dietary habits and adenomatous polyps of the sigmoid colon: A study of self-defense officials in Japan
94. Physical activity and the risk of colorectal adenomas
95. Exercise and sports therapy for patients with head and neck tumors
96. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer
97. An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation
98. Music therapy in palliative care
99. Music and emotion in palliative care
100. An introduction to music therapy: Helping the oncology patients in the ICU
101. Healing sounds
102. The benefits of group music at the 1996 music weekend for women with cancer
103. The therapeutic use of music for cancer-related pain
104. Music therapy in pain and symptom management
105. The influence of personal message with music on anxiety and side effects associated with chemotherapy